Cardiac iPSCs for Disease Modeling and Drug Discovery

preview_player
Показать описание
CVI Frontiers in Cardiovascular Science
11-04-2014

Joseph Wu, MD, PhD, Professor of Medicine (Cardiology) and Radiology, Stanford University. Director of the Stanford Cardiovascular Institute.

"Cardiac iPSCs for Disease Modeling and Drug Discovery"
  1. Stanford Cardiovascular Institute
  2. CVI
  3. Cardiovascular
  4. Stanford University (College/University)
  5. Stanford Cardiovascular Institute
  6. Cardiovascular Institute
Рекомендации по теме
Cardiac iPSCs for 0:49:52

Cardiac iPSCs for Disease Modeling and Drug Discovery

iPSCs for cardiovascular 0:36:16

iPSCs for cardiovascular diseases

Heart disease in 0:51:40

Heart disease in a dish: Human iPSC-derived multicellular cardiac organoids

Generation of induced 0:25:05

Generation of induced pluripotent stem cell-derived cardiomyocytes for disease modeling

Using Patient Specific 0:40:14

Using Patient Specific iPSC-Cardiomyocytes for Disease Modeling

Paul Burridge: Disease 0:18:24

Paul Burridge: Disease modeling and human IPSCs

Using cutting-edge stem 0:28:52

Using cutting-edge stem cell technology to model human cardiac diseases

Human pluripotent stem 1:00:59

Human pluripotent stem cells in understanding genetic cardiovascular disease and effects of drugs

Re-introducing the Patient 0:34:00

Re-introducing the Patient Context into Cardiac Drug Discovery Using iPSCs

Iacone and Swanson 1:05:33

Iacone and Swanson - Diabetic Cardiomyopathy Modeling & Screening with iPSC Cardiomyocytes

Human iPSC-based disease 0:59:40

Human iPSC-based disease modeling and therapeutic development

SPS 2018: Implementing 0:35:21

SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease Modeling

Human iPSC-Derived Cardiomyocytes, 0:02:01

Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, & Endothelial Cells l Protocol Preview

Making Pluripotent Stem 0:02:22

Making Pluripotent Stem Cells

Induced PSCs for 0:13:40

Induced PSCs for CV Disease Modeling and Precision Medicine

Todd J Herron 0:49:27

Todd J Herron - Generation of purified human iPSC derived cardiomyocytes...

iPSC derived Cardiomyocytes 0:14:16

iPSC derived Cardiomyocytes for Predicting and Removing Drug Cardiotoxicity - Mark Mercola

Differentiation of human 0:23:25

Differentiation of human pluripotent stem cells into atrial and ventricular cardiomyocyte subtypes

Insights to Heart 0:58:34

Insights to Heart Development and Disease using Single Cell Analysis and In Vitro Modeling of Plurip

WSCS 2014: STEM 0:56:49

WSCS 2014: STEM CELLS FOR DISEASE MODELING

Predictive Human Induced 1:01:00

Predictive Human Induced Pluripotent Stem Cell-derived Cardiomyocyte Model of Cardiotoxicity

Advances in Modeling 0:49:19

Advances in Modeling Human Diseases Using Induced Pluripotent Stem Cell-derived Cellular Models

APS Physiology in 1:28:06

APS Physiology in Disease Modeling and Drug Development Roundtable

Improvements in building 0:27:45

Improvements in building in vitro pluripotent stem cell-derived disease models